Toward a Typology of Patients With Head and Neck Cancer: Biopsychosocial Profiles Predicting Longitudinal Quality of Life - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Developing a Patient Typology for Head and Neck Cancer: Biopsychosocial Factors Influencing Long-Term Quality of Life

  • By

  • Haley Deamond

  • Cyril Devault-Tousignant

  • Jacob Lang

  • Christopher Lo

  • Jennifer Silver

  • Nader Sadeghi

  • Zeev Rosberger

  • Saul Frenkiel

  • Michael Hier

  • Anthony Zeitouni

  • Karen Kost

  • Alex Mlynarek

  • Keith Richardson

  • Gabrielle Chartier

  • Marco Mascarella

  • Khalil Sultanem

  • Georges Shenouda

  • Fabio Cury

  • Melissa Henry

  • March 11, 2026

Share

Objective:

To delineate biopsychosocial risk profiles associated with compromised quality of life (QoL) during the first year following a first occurrence of head and neck cancer (HNC).

Approach:
  • Outcome Measure: QoL evaluated using the Functional Assessment of Cancer Therapy—General and Head and Neck Module (FACT-HN), which assesses participants' QoL over the past week.
Key Findings:
  • QoL in HNC patients is influenced by a range of biopsychosocial factors including medical comorbidities, psychological health, and social support.
  • Distinct patient profiles with varying QoL trajectories were identified using machine learning clustering algorithms.
  • Psychological factors were strongly associated with longitudinal QoL outcomes.
Interpretation:

The study suggests that understanding the interplay of biopsychosocial factors can help identify patient groups vulnerable to poor QoL post-HNC treatment.

Limitations:
  • The study's findings may not be generalizable beyond the specific cohort studied.
  • Potential biases in self-reported measures and participant selection.
Conclusion:

Characterizing biopsychosocial risk profiles may lead to personalized interventions to improve QoL in HNC patients.

Original Source(s)

Toward a Typology of Patients With Head and Neck Cancer: Biopsychosocial Profiles Predicting Longitudinal Quality of Life

  • by Haley Deamond, Cyril Devault-Tousignant, Jacob Lang, Christopher Lo, Jennifer Silver, Nader Sadeghi, Zeev Rosberger, Saul Frenkiel, Michael Hier, Anthony Zeitouni, Karen Kost, Alex Mlynarek, Keith Richardson, Gabrielle Chartier, Marco Mascarella, Khalil Sultanem, Georges Shenouda, Fabio Cury, Melissa Henry

  • March 11, 2026

Related Content

Retraction Note: TWIST1 activates cancer stem cell marker genes to promote epithelial‑mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma

Case Report: Treatment of an unresectable mucoepidermoid carcinoma with osimertinib

Correction: Stem-like CD4 T cells in tumors: an emerging framework for antitumor immunity